在Acinetobacter baumannii中,从临床标本中分离出的多重耐药性和生物膜形成
Poonam Yadav1, Shyam Kumar Mishra2, Sreska Shrestha1
1Department of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Journal of Nepal Health Research Council
|March 18, 2025
概括
具有多种耐药性的Acinetobacter baumannii构成重大威胁,其中97.5%的分离物对常见抗生素具有耐药性. 聚米克辛仍然有效,而产生卡巴酶的菌株通常形成强大的生物膜,突出显示了治疗中的关键挑战.
科学领域:
- 临床微生物学 临床微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是一个重要的医院病原体.
- 它的出现与抗生素耐药性和生物膜形成有关.
- 了解这些特征之间的相关性对于有效治疗至关重要.
研究的目的:
- 为了研究Acinetobacter baumannii分离物中的抗生素耐药性模式.
- 评估这些隔离物中生物膜形成的流行率.
- 确定抗生素耐药性和生物膜产生的关系.
主要方法:
- 在尼泊尔的Tribhuvan大学教学医院进行了横截面研究.
- 使用标准指南和表型测试进行抗生素敏感性测试和β-乳糖酶检测.
- 通过微型板方法进行生物膜形成评估.
主要成果:
- 97.5%的Acinetobacter baumannii分离物是多药耐药 (MDR) 的.
- 单独的MDR仅对多胺素敏感;对胺素和卡巴胺的耐药性是普遍的.
- 83.1%的生物膜生成分离物是强生产者; gentamicin 耐药性与生物膜形成相关.
结论:
- 聚米克辛是唯一有效的治疗方法来对抗MDR Acinetobacter baumannii.
- 碳烯酶的产生与强大的生物膜形成有关.
- 研究结果提供了对抗药性机制的见解,并为MDR Acinetobacter baumannii感染管理提供了信息.
更多相关视频
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
3.0K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
505
相关概念视频
01:29Biofilms
2.1K
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
2.1K
01:30Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
01:25Mechanism of Antibiotic Resistance in MRSA
245
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245
01:25Clinical Significance of Antibiotic Resistance
106
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106